Healthcare


Innovations in Drug Discovery and Development for Neurological, Cancer, and Cardiovascular Applications

Share this:
Published: 11 May 2018

This Drug Discovery TechVision Opportunity Engine (TOE) depicts new life sciences trends across drug discovery platforms focused on neurological, oncological, and cardiovascular application areas. In vivo, in vitro, and in silico models are depicted, integrating the remarkable synergy among biological innovations such as checkpoint inhibitors, stem cells, and transposons, and machine learning artificial intelligence-based approaches. Clinical trials for treatments based on RNA targeting technologies are also depicted. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Animal models, human brain organoids, disease models, biomimicry, neurodegenerative disorders, Zika Virus, CGRP inhibitor, migraine prevention, KRAS, cancer management, tolperisone, neuromuscular spasms, technology convergence, regenerative cardiovascular therapy, regenerative medicine, autophagy, therapeutic breakthroughs, machine learning platforms, drug development, RNA targeting technologies

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..